Ophthalmologic manifestations in patient with rheumatoid arthritis
Abstract
Background: rheumatoid arthritis is the prototype of systemic autoinmune disease. It affects mainly synovial articulations, with less frequency extrarticular tissues. When it affects the organ of the vision, it is part of important ophthalmological manifestations.
Objective: to identify the ophthalmological manifestations found in patients diagnosed with rheumatoid arthritis.
Methods: a descriptive transversal study was carried out in Dr. Octavio de la Concepción y la Pedraja hospital in Camagüey from January to December 2015. The universe was composed of 55 patients remitted to the service of Ophthalmology, coming from Rheumatology consultation diagnosed with AR who presented ophthalmological manifestations and that fulfilled the defined inclusion approaches for the author. The data was picked up in a survey validated by experts. Variables of clinical characterization were considered as: ophthalmological manifestations and time of evolution of the rheumatic illness and age and sex were biological. For the the data processing descriptive statistics was used for the distribution of absolute and relative frequencies.
Results: dry queratoconjuntivitis was the most frequent ophthalmological manifestation, followed by Sjögren’s syndrome in order of frequency by and epiescleritis. Uveitis, escleritis and cataract were less frequent. Female sex prevailed; patients between 40 and 59 years were more affected, as well as those that had between 5 and 9 years of evolution of the rheumatic disease.
Conclusions: ophthalmological manifestations of the AR were frequent, dry queratoconjuntivitis, the syndrome of Sjögren and the epiescleritis stood out. A meticulous and multidisciplinary study of the ill person is required; for the early diagnosis, appropriate therapy and prevention of the ocular complications that can end up being disabling.
DeCS: EYE MANIFESTATIONS; ARTHRITIS, RHEUMATOID; KERATOCONJUNCTIVITIS; ADULT; EPIDEMIOLOGY, DESCRIPTIVE.
Downloads
References
1. Vaz AE, Faria J, Wilmar A, Lazarski, Ferreira S, Carmo Franco H do, et al. Perfil epidemiológico e clínico de pacientes portadores de artrite reumatóide em um hospital escola de medicina em Goiânia, Goiás, Brasil. Medicina Ribeirão Preto [Internet]. Abr-Jun 2013 [citado 7 Ago 2015];46(2):[aprox. 2 p.]. Disponible en: http://bvsalud.org/portal/resource/en/lil-708152
2. David JM, Mattei RA, Mauad JL, Almeida LG de, Nogueira MA, Menolli PV, et al. Estudo clínico e laboratorial de pacientes com artrite reumatoide diagnosticados em serviços de reumatologia em Cascavel, PR, Brasil. Rev Bras Reumatol [Internet]. Feb 2013 [citado 7 Ago 2015];53(1):[aprox. 3 p.]. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042013000100006&lng=es
3. Gómez Morales J, Blanco Cabrera Y, Llópiz Morale M, Reyes Pineda Y, Solís Cartas E. Manifestaciones oftálmicas derivadas del tratamiento de las enfermedades reumáticas. Rev Cubana Reumatol [Internet]. 2015 [citado 25 Mar 2015];17(1):[aprox. 5 p.]. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/390/pdf_9. 3
4. Ramírez Jiménez AR, Ruiz Olivera A, Melo Ruiz V, García M. Alternativa con gel de Papaversomniferum (amapola) y Cannabis sativa (marihuana), como tratamiento de artritis reumatoide. Enf Neurol (Mex) [Internet]. 2011 [citado 25 Mar 2015];10(1):[aprox. 3 p.]. Disponible en: http://www.medigraphic.com/pdfs/enfneu/ene-2011/ene111d.pdf
5. Arbieto J, Ever R. Prevalencia de depresión en pacientes con artritis reumatoide en el Hospital Regional de Huacho. [Internet]. Lima: Universidad Nacional Mayor de San Marcos; 2013 [citado 25 Mar 2015]. Disponible en: http://ateneo.unmsm.edu.pe/ateneo/bitstream/123456789/2696/1/Jaque_Arbieto_Raffy_Ever_2013.pdf
6. Cohen S, Emery P. The American College of Rheumatology/European League Against Rheumatism Criteria for the classification of rheumatoid arthritis: a game changer. Ann Rheum Dis [Internet]. 2010 [citado 2015 Mar 25];69(9):[about 4 p.]. Available from: http://ard.bmj.com/content/69/9/1575.short
7. Badot V. Early diagnosis of rheumatoid arthritis. Rev Med Brux [Internet]. 2015 Sep [citado 2015 Apr 3];35(4):[about 2 p.]. Available from: Disponible en:http://preview.ncbi.nlm.nih.gov/pubmed/25675622
8. Mota LM, Cruz H da, Afonso B, Viegas BC, Pereira Alves I, Fronza L, et al. Consenso da Sociedade Brasileira de Reumatologia 2011 para o diagnóstico e avaliação inicial da artrite reumatoide. Rev Bras Reumatol [Internet]. May-Jun 2011 [citado 3 Abr 2015];51(3):[aprox. 5 p.]. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/25675622
9. Piñeiro N, Correa Fernando RA. Tratamiento de la Artritis Reumatoidea con AntiTNF: Experiencia en Uruguay. Arch Med Int [Internet]. 2012 [citado 6 Ago 2015];34(2):[aprox. 2 p.]. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-423X2012000200002&lng=es
10. Virasch V, Richard D, Brasingtony A, Lubniewski J. Corneal disease in rheumatoid arthritis. In: Krachmer JH, Mannis MJ, Holland E, editors. Cornea. 3ra ed. Madrid: Elsevier; 2011. p. 1117-32.
11. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular Manifestations in Rheumatoid Arthritis. J Clin Med [Internet]. 2010 Dic [citado 2015 Aug 6];5(4):[about 3 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152850/.
12. Ortega Sotolongo M, Luaces Martínez Á, Nápoles Álvarez A, Reyes Pineda Y, Gil Armenteros RG, Ventura Muñoz M. Afectaciones oftalmológicas en pacientes con enfermedades reumáticas. Rev Cubana Reumatol [Internet]. Ene-Abr 2016 [citado 14 Abr 2016];18(1):[aprox. 5 p.]. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/453
13. Zlatanović G, Veselinović D, Cekić S, Zivković M, Dorđević-Jocić J, Zlatanović M. Ocular manifestation of rheumatoid arthritis-different forms and frequency. Bosn J Basic Med Sci [Internet]. 2010 Nov [citado 2015 Ago 2015];10(4):[about 5 p.]. Available from: http://www.researchgate.net/profile/Sonja_Cekic/publication/49636686_Ocularmanifestation_of_rheumatoid_arthritisdifferent_forms_and_frequeny/links/00463521d0e56e0586000000.pdf
14. Mohsenin A, Huang JJ. Ocular manifestations of systemic inflammatory diseases. Europe PudMed Central [Internet]. 2012 Oct [citado 2015 Aug 06];76(9):[about 2 p.]. Available from: http://europepmc.org/abstract/med/23155672
15. Quignon Santana SS, Alfonso Sánchez O. Principales manifestaciones oculares en la artritis reumatoide modelos de diagnóstico y evaluación. MediSur [Internet]. Nov-Dic 2009 [citado 25 Mar 2015];7(6):[aprox. 2.p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2009000600009&lng=es&nrm=iso
16. Markovitz E, Perry ZH, Tsumi E, Abu-Shakra M. [Ocular involvement and its' manifestations in rheumatoid arthritis patients]. Harefuah [Internet]. 2011 Sep [citado 2015 Aug 6];159(5):[about 6 p.]. Available from: http://europepmc.org/abstract/med/22026055
17. Reyes Medina EA, Nerey González W, Suárez Rodríguez BL, Egüez Mesa JL. Caracterización clínico-epidemiológica de los pacientes con artritis reumatoide. Hospital Universitario Arnaldo Milián Castro. Rev Cubana Reumatol [Internet]. Abr 2015 [citado 16 Nov 2016];17(1):[aprox. 2 p.]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962015000100004&lng=es
18. Gómez Morales J, LLópiz Morales M, Luaces Martínez A, Blanco Cabrera Y, Viera Rosales M, Solis Cartas U. Comportamiento de las Manifestaciones oftalmológicas en pacientes con artritis reumatoide. Rev Cuba Reumatol [Internet]. Ago 2015 [citado 14 Abr 2016];17(2):[aprox. 3 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S181759962015000200008&lng=es
19. Vignesh AP, Srinivasan R. Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies. Clin Ophthalmol [Internet]. 2015 Feb [citado 2015 Aug 6];25(9):[about 4 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25750517
20. Bongartz T, Cantaert T, Atkins SR, Harle P, Myers JL, TuressonC, et al. Cirullination in extra-articular manifestations of rheumatoid arthritis. Rheumatol (Oxford) [Internet]. 2007 [citado 2015 Aug 6];46(1):[about 6 p.]. Available from: http://rheumatology.oxfordjournals.org/content/46/1/70.short
21. Zlatanović G, Veselinović D, Cekić S, Živković M, Đorđević- Jocić J, Zlatanović M. Ocular manifestation of rheumatoid arthritis - different forms and frequency. Bosnian J Basic Med Scien [Internet]. 2010 [citado 2015 Aug 6];10(4):[about 6 p.]. Available from: https://www.researchgate.net/profile/Sonja_Cekic/publication/49636686_Ocular_manifestation_of_rheumatoid_arthritisdifferent_forms_and_frequency/links/00463521d0e56e0586000000.pdf
22. Kraus CL, Culican SM. Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease. Int J Rheumatol [Internet]. 2012 [citado 2015 Aug 6];46(1):[about 2 p.]. Available from: http://www.hindawi.com/journals/ijr/2012/203819/.
23. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis [Internet]. 2002 [citado 2015 Aug 6];61(6):[about 6 p.]. Available from: http://ard.bmj.com/content/61/6/554.short
24. Kosrirukvongs P, Ngowyutagon P, Pusuwan P, Koolvisoot A, Nilganuwong S. Prevalence of dry eye syndrome and Sjogren's syndrome in patients with rheumatoid arthritis. J Med Assoc Thai [Internet]. 2012 Apr [citado 2015 Aug 6];95(Suppl4):[about 6 p.]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22696854
25. Beardsley RM, Suhler EB, Rosenbaum JT, Lin P. Pharmacotherapy of Scleritis: Current Paradigms and Future Directions. Expert Opin Pharmacother [Internet]. 2013 Mar [citado 2015 Aug 6];14(4).[about 4 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888795/.
26. Crostein BN. Interleukin 6 a key mediator of systemic and local symptoms in rheumatoidarthritis. Bull NYU Hosp J [Internet]. 2007 Dic [citado 2015 Mar 25];65(Suppl 1):[about 4 p.]. Available from: http://preview.ncbi.nlm.nih.gov/pubmed/?term=Crostein+BN.+Interleukin 6+%E2%80%93+a+key+mediator+of+systemic+and+local+symptoms+in+rheumatoidarthritis
27. Galor A, Thorne JE. Scleritis and Peripheral Ulcerative Keratitis. Rheum Dis Clin North Ame [Internet]. 2007 Nov [citado 2015 Aug 6];33(4):[about 2 p.]. Available from: http://www.sciencedirect.com/science/article/pii/S0889857X07000543
28. Carbone J, Sarmiento E, Micheloud D, Rodríguez-Mahou M, Rodríguez-Molina JJ. Enfermedad autoinmune sistémica en pacientes con uveítis. Arch Soc Esp Oftalmol [Internet]. Abr 2006 [citado 2 Nov 2015];81(4):[aprox. 6 p]. Disponible en: http://scielo.isciii.es/pdf/aseo/v81n4/original1.pdf
29. Kanski J, Bowling B, Nischal K, Pearson A. Efectos secundarios oculares de la medicación sistémica. En: Kanski J. Bowling B, Nischal K, Pearson A, editores. Oftalmología clínica. 7ma ed. Ámsterdam: Elsevier; 2012. p. 861-8.
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025